Think you know AARP? What you don't know about us may surprise you. Discover all the 'Real Possibilities'




AARP Real Possibilities
Car buying made easy with the AARP Auto Buying Program


Piggy bank on the road - AARP Driver Safety

Take the new AARP Smart Driver Course!

Contests and

Dream Vacation Sweepstakes

10 weeks. 10 amazing trips. Seize your chance to win!
See official rules. 


ATM Mobile App for iPhone and Ipad

Enjoy the best of AARP’s award-winning publications

on the go with the new

AARP ePubs iPad App


AARP Games - Play Now!

Learning Centers

Get smart strategies for managing health conditions.


Heart Disease


Most Popular



Ask the Pharmacist

Do Drugs for Treating Early-Stage Alzheimer’s Work?

Or do the risks outweigh the benefits?

Dream Vacation Sweepstakes

10 weeks. 10 amazing trips. Seize your chance to win! Official rules.

En español | Q: My great aunt’s doctor suggested that she start taking donepezil (a cholinesterase inhibitor marketed under the brand name Aricept) for her early-stage Alzheimer’s.

Portrait of a younger and older woman smiling illustrates story about a drug for alzheimer's disease

Family members often have to decide whether a loved one with Alzheimer's can benefit from medication. — Thomas Barwick/Getty Images

When I looked up the drug, I was surprised to learn that it generally gives people only a small, short-term (less than six months) boost in cognitive functioning.

I also read that the medication has a lot of side effects, although most of the time not severe. If that’s true, why should my great aunt — or anyone, for that matter — take this type of drug?

A. Cholinesterase inhibitors such as donepezil are commonly prescribed to individuals with Alzheimer's disease and other types of dementia.

These drugs are thought to work by inhibiting the enzyme in the body that breaks down acetylcholine (a neurotransmitter that's important for alertness, memory, thought and judgment) and thus boosting the amount available to brain cells. This, in theory, slows the patient’s loss of memory and helps them perform daily activities with fewer problems.

I say “in theory” because in the many years since tacrine (Cognex), the first cholinesterase inhibitor, was introduced in 1993, reviews of these drugs have found that they do not lead to meaningful improvements in patient symptoms. The most recent analysis of clinical trials of donepezil, for example, published in 2006 by the Cochrane Collaboration, a nonprofit network of medical researchers who review drug studies, concluded that “the treatment effects are small and are not always apparent in practice.”

Additionally, the incidence of adverse events from this class of drugs is very high, and the older a person is, the greater the problems are likely to be. A study published in the Archives of Internal Medicine in 2009, for example, reported that these drugs can cause symptomatic bradycardia (low heart rate), leading to the permanent insertion of a pacemaker, and syncope (fainting or loss of consciousness). Especially worrisome is the fact that drug-induced syncope may precipitate fall-related injuries, including hip fractures.

Because acetylcholine is everywhere in the body, not just in the brain, blocking its breakdown can interfere with all kinds of involuntary body processes and movements. That can mean episodes of diarrhea, urinary incontinence, confusion, dehydration, depression, gastric disorders (from cramps to gastrointestional bleeds), hallucinations, headaches, and on and on and on.

Next: Protecting a loved one from the "prescribing cascade." >>

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts


Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Health blog

Discounts & Benefits

bring health To Life-Visual MD

AARP Bookstore

AARP Bookstore - woman reaches for book on bookshelf


Find titles on brain health, drug alternatives and losing weight. Do